BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Despite major advances in prevention and medical therapy, heart failure (HF) remains
associated with high morbidity and mortality, especially in older and frailer patients …

Importance Heart failure with improved ejection fraction (HFimpEF), defined as prior left
ventricular ejection fraction (LVEF) 40% or lower that has increased to greater than 40%, is …

Summary Background Mineralocorticoid receptor antagonists (MRAs) reduce
hospitalisations and death in patients with heart failure and reduced ejection fraction …

BACKGROUND: Apparent treatment-resistant hypertension (aTRH) is prevalent and
associated with adverse outcomes in heart failure with mildly reduced or preserved ejection …

BACKGROUND: Although frailty is strongly associated with mortality in patients with heart
failure (HF), the risk of which specific cause of death is associated with being complicated …

Introduction and objectives Noncardiovascular events represent a significant proportion of
the morbidity and mortality burden in patients with heart failure (HF). However, the risk of …

Aims Current guidelines recommend implantable cardioverter‐defibrillator (ICD) therapy in
patients with heart failure, a left ventricular ejection fraction of≤ 35%, and New York Heart …

Background: Patients with atrial fibrillation (AF) and heart failure (HF) have elevated left
ventricular end-diastolic pressure in addition to decreased left atrial (LA) function, but there …

Objective: Results from large placebo-controlled randomized trials in patients with heart
failure with mid-range ejection fraction (HFmrEF) and HF with preserved EF (HFpEF) have …